Articles

Global Pathogen Variants

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya

by Doreen Lugano, Bernadette Kutima, Makobu Kimani, Antipa Sigilai, John Gitonga, Angela Karani,, Donald Akech, Boniface Karia, Abdhalah K. Ziraba, Angela Maina, Arnold Lambisia, Donwilliams Omuoyo, Daisy Mugo, Ruth Lucinde, Sharon Owuor, Gloria Konyino, Joseph Newman, Dalan Bailey,, Eunice Nduati, George Githinji, Charles N. Agoti, Philip Bejon, J. Anthony G. Scott,, Ambrose Agweyu, Wangeci Kagucia, George M. Warimwe, Charles Sande, Lynette I. Ochola-Oyier, James Nyagwange

  Increased immune evasion by emerging and highly mutated SARS-CoV-2 variants is a key challenge to the control of COVID-19. The majority of these mutations mainly target the spike protein, ...

News

Call for Proposals for Implementing Partners for the Global South Leaders in Epidemic Analytics and Response Network (GS LEARN)

CEPI and the Gates Foundation are launching a network of partners that could provide rapid epidemic modelling to inform response to future infectious disease threats

To build the network, CEPI and Gates are seeking experts to offer training and mentorship to researchers and professionals in Global South institutions on epidemic and pandemic data analytics and infectious disease modelling Read more

Enable 1.5 recruitment concludes at three Nigerian sites

Recruitment of participants for Enable 1.5, a programme focusing on the epidemiology of Lassa fever ahead of late-stage vaccine trials, has rapidly concluded at three sites in Ondo, Edo, and Ebonyi states

With huge thanks to coordination by CEPI’s Enable team, headed by Dr Henshaw Mandi, and partners, each site has recruited 1,000 participants. Two other countries, Sierra Leone and Liberia, will begin enrolment in early 2025. Read more

A novel study investigates the burden of chikungunya in East Africa

The mosquito-borne virus causes outbreaks in the Americas and Asia, but remains understudied in Africa

A team of scientists from the UK, Kenya, and Tanzania will explore the extent to which chikungunya affects countries in East Africa. The results will be crucial in guiding the design and implementation of future vaccine trials. Read more

SPEAC's Vaccine Safety Resources for Mpox

SPEAC has a new page with vaccine safety resources for mpox

The resource page features a protocol template (for cohort event monitoring for active safety surveillance after vaccination with mpox vaccines), a list of adverse events of special interest, CEM questionnaires, an adult informed consent form, key elements for data collection... Read more

Older News Here |